Brief: Geneuro Announces Positive 6-Month Phase IIA Data For GNBAC1

Geneuro SA

26/09/2018 06:35

Sept 26 (Reuters) - GENEURO SA  GNRO.PA :
    * GENEURO ANNOUNCES POSITIVE 6-MONTH PHASE IIA DATA FOR
GNBAC1 IN
ADULTS WITH TYPE 1 DIABETES
    * PHASE IIA RAINBOW STUDY MET ALL PRIMARY SAFETY ENDPOINTS
IN THIS
NEW PATIENT POPULATION
    * OPENS PATH FOR DEVELOPMENT IN LARGER POPULATIONS WITH MORE
RECENT DISEASE ONSET
    * 12-MONTH RESULTS WILL BE AVAILABLE IN 1Q2019

Source text for Eikon:  ID:nBw1r77Vma 
Further company coverage:  GNRO.PA 

 (Gdynia Newsroom:)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))